Stress-dependent growth in breast cancer arises from a mechano-osmotic coupling and cell-sizing checkpoint
Proceedings of the National Academy of Sciences · 10.03.2026 · 123 (10)
DOI: 10.1073/pnas.2523159123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 04.03.2026. Verfasst von Irish Senthilkumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Engineering and Institute for Health Discovery and Innovation, College of Science and Engineering, University of Galway, Galway H91 TK33, …. Hauptthemen laut MEDLINE: Breast Neoplasms, Mechanotransduction, Cellular, Stress, Physiological. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Irish Research Council (IrishResearch), EC | European Research Council (ERC), Research Foundation Flanders.
Abstract (Originalsprache)
Mechanoresponsive cell proliferation is a feature of growing tumors, despite the suppression of many other regulatory checkpoints in cancer, but the underlying cell-scale mechanisms driving this behavior have not yet been established. In this study, we propose a biophysical model for cell growth as governed by actively controlled osmolarity, which we integrate with a discrete particle framework to simulate growth and remodeling of breast cancer spheroids. Confinement and biomechanical feedback from the extracellular environment are analyzed through a neural-network-accelerated finite element solver. Combining the framework with experiments, our model reveals that stress-dependent spheroid growth can arise from a sizing checkpoint for mitosis. Under sufficient extracellular loading, cell growth is restricted by high hydrostatic forces in competition with osmotic pressure from biomolecule synthesis, which prevents cells from surpassing a critical volume. Our model provides insight into mechanosensitive growth arrest in breast cancer, potentially serving as a computational tool for analyzing growth in a wider range of normal and malignant biological tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Engineering and Institute for Health Discovery and Innovation, College of Science and Engineering, University of Galway, Galway H91 TK33, Ireland.
- School of Computer Science and Data Science Institute, University of Galway, Galway H91 TK33, Ireland.
- Mechatronics, Biostatistics, and Sensors (MeBIOS) division, Department of Biosystems, KU Leuven, Leuven 3001, Belgium.
- Mechanobiology and Medical Device Research Group, Biomedical Engineering, College of Science and Engineering, University of Galway, Galway H91 TK33, Ireland.
- CÚRAM, Research Ireland Centre for Medical Devices, University of Galway, Galway H91 TK33, Ireland.
ORCID-Profile: Jef Vangheel, Bart Smeets, Eoin McEvoy
Förderung
- Irish Research Council (IrishResearch)
- EC | European Research Council (ERC)
- Research Foundation Flanders
Zitieren
APA
Senthilkumar, I., Vangheel, J., Kumar, V., McNamara, L., Smeets, B., Howley, E., & McEvoy, E. (2026). Stress-dependent growth in breast cancer arises from a mechano-osmotic coupling and cell-sizing checkpoint. Proceedings of the National Academy of Sciences, 123(10). https://doi.org/10.1073/pnas.2523159123
Vancouver
Senthilkumar I, Vangheel J, Kumar V, McNamara L, Smeets B, Howley E, et al. Stress-dependent growth in breast cancer arises from a mechano-osmotic coupling and cell-sizing checkpoint. Proceedings of the National Academy of Sciences. 2026;123(10). doi:10.1073/pnas.2523159123
BibTeX
@article{Senthilkumar2026,
author = {Senthilkumar, Irish and Vangheel, Jef and Kumar, Vatsal and McNamara, Laoise and Smeets, Bart and Howley, Enda and McEvoy, Eoin},
title = {Stress-dependent growth in breast cancer arises from a mechano-osmotic coupling and cell-sizing checkpoint},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {10},
doi = {10.1073/pnas.2523159123}
}
EUVIMED